Rowland Carmichael Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$667K Hold
3,301
0.21% 109
2020
Q3
$694K Hold
3,301
0.27% 96
2020
Q2
$724K Sell
3,301
-230
-7% -$46K 0.31% 85
2020
Q1
$612K Hold
3,531
0.31% 90
2019
Q4
$542K Buy
3,531
+3
+0.1% +$448 0.19% 135
2019
Q3
$536K Buy
3,528
+18
+0.5% +$2.85K 0.18% 132
2019
Q2
$537K Hold
3,510
0.19% 139
2019
Q1
$563K Sell
3,510
-320
-8% -$49.6K 0.21% 131
2018
Q4
$590K Hold
3,830
0.26% 102
2018
Q3
$576K Hold
3,830
0.22% 117
2018
Q2
$518K Sell
3,830
-420
-10% -$51.8K 0.22% 116
2018
Q1
$566K Sell
4,250
-151
-3% -$20.3K 0.31% 99
2017
Q4
$655K Buy
4,401
+571
+15% +$77.7K 0.34% 93
2017
Q3
$505K Hold
3,830
0.28% 117
2017
Q2
$510K Hold
3,830
0.3% 107
2017
Q1
$516K Hold
3,830
0.31% 102
2016
Q4
$460K Sell
3,830
-155
-4% -$18.3K 0.27% 118
2016
Q3
$499K Hold
3,985
0.32% 104
2016
Q2
$551K Buy
3,985
+1,020
+34% +$132K 0.35% 97
2016
Q1
$374K Buy
+2,965
New +$377K 0.35% 98

Other funds holding CLX

Rowland Carmichael Advisors's CLX Position: Q4 2020 in Review

Rowland Carmichael Advisors held its Clorox (CLX) position steady in Q4 2020 at 3,301 shares worth $667K. The position accounts for 0.21% of the portfolio, ranked #109.

Rowland Carmichael Advisors first reported a position in CLX in Q1 2016 and has held it in 20 quarters since. The position peaked at $724K in Q2 2020. 1,262 funds tracked by Wall St. Rank hold CLX as of Q4 2020.

  • Rowland Carmichael Advisors held 3,301 shares of Clorox worth $667K as of Q4 2020.
  • Rowland Carmichael Advisors left its Clorox share count unchanged in Q4 2020.
  • Clorox made up 0.21% of Rowland Carmichael Advisors's portfolio in Q4 2020, its #109 holding.
  • Rowland Carmichael Advisors first reported a position in Clorox in Q1 2016 and has held it in 20 quarters since.
  • Rowland Carmichael Advisors's Clorox position peaked at $724K in Q2 2020.
  • 1,262 funds tracked by Wall St. Rank held Clorox as of Q4 2020.

Based on Rowland Carmichael Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.